Ceribell
✓ Verified
Healthcare AI
AI-powered point-of-care EEG / neurodiagnostics
Public
Ceribell is a commercial-stage medical technology company focused on AI-powered point-of-care EEG for rapid seizure detection and monitoring in acute care settings, including emergency departments and intensive care units. Its platform combines portable hardware with AI software such as Clarity and is positioned as a bedside neurodiagnostic tool for faster clinical decision-making.
Company Details
- Website
- ceribell.com
- Headquarters
- Sunnyvale, California, USA
- Founded
- 2014
- Funding
- More than $150M pre-IPO; IPO raised $180.3M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring